Virax Biolabs Group Limited Gains 41.3%

Tue, Sep 20, 2022 at 07:20 PM
Virax Biolabs Group Limited Gains 41.3%

Virax Biolabs Group Limited (VRAX:NASDAQ) jumped higher at $3.49, representing a gain of 41.3%. On Tue, Sep 20, 2022, VRAX:NASDAQ hit a New 2-Week Intraday High of $3.74. The stock appeared on our News Catalysts scanner on Tue, Sep 20, 2022 at 10:24 AM in the 'BIOTECH' category. From Tue, Sep 06, 2022, the stock recorded 30.00% Up Days and 27.27% Green Days

The stock spiked on Thu, Sep 01, 2022 at $6.1 with a volume of 21M+.

About Virax Biolabs Group Limited (VRAX:NASDAQ)

Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of...

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.